Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Colo-rectal Cancer
- RAS Wild Type
- UICC II + RF
- UICC III
- UICC IV Curative Intent
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03263663
- Collaborators
- MGO Ruhr-University Bochum (RUB)
- Investigators
- Principal Investigator: Sebastian Stintzing, Prof. Dr. Senior Physician